Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H20N2.C10H15NO3 |
| Molecular Weight | 437.5744 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)[C@@H]1NC(=O)C(C(C)=O)=C1O.C(CNCC2=CC=CC=C2)NCC3=CC=CC=C3
InChI
InChIKey=AUADKTQXHWIAAX-BLZOLZRRSA-N
InChI=1S/C16H20N2.C10H15NO3/c1-3-7-15(8-4-1)13-17-11-12-18-14-16-9-5-2-6-10-16;1-4-5(2)8-9(13)7(6(3)12)10(14)11-8/h1-10,17-18H,11-14H2;5,8,13H,4H2,1-3H3,(H,11,14)/t;5-,8-/m.0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12111715Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17379181
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12111715
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17379181
Tenuazonic acid is one of the major Alternaria mycotoxins commonly found as a natural contaminant in food. Tenuazonic acid contamination has been linked to esophageal cancer in human populations at risk of high exposure. Tenuazonic acid inhibits protein synthesis by suppression at the ribosome. Tenuazonic acid was shown to inhibit 12-O-tetradecanoyl phorbol-13-acetate (TPA) induced ornithine decarboxylase (ODC) activity in a mouse model, and in turn suppressed mouse skin tumor promotion. In addition, this compound has been shown to be a new type of Photosystem II inhibitor.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evaluation of an enzyme immunoassay for the detection of the mycotoxin tenuazonic acid in sorghum grains and sorghum-based infant food. | 2017-02 |
|
| Determination of Exposure to the Alternaria Mycotoxin Tenuazonic Acid and Its Isomer allo-Tenuazonic Acid in a German Population by Stable Isotope Dilution HPLC-MS(3). | 2016-08-31 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/?term=12111715
in mice: (skin carcinogenesis): Female Swiss albino mice were exposed topically to 100 nmole of 7,12-dimethyl benz(a) antracene (DMBA) twice weekly for 20 weeks. Another group of animals was treated with 250 microg tenuazonic acid (TA) in acetone daily for a period of 1 week, followed by the same dose of TA prior to every application of DMBA.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17379181
Curator's Comment: The results of competitive replacement with [(14)C]atrazine combined with JIP-test and D1-mutant showed that Tenuazonic acid (TeA) should be considered as a new type of photosystem II inhibitor because it has a different binding behavior within Q(B)-niche from other known photosystem II inhibitors.
Unknown
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
21327-82-2
Created by
admin on Tue Apr 01 19:31:33 GMT 2025 , Edited by admin on Tue Apr 01 19:31:33 GMT 2025
|
PRIMARY | |||
|
909881-75-0
Created by
admin on Tue Apr 01 19:31:33 GMT 2025 , Edited by admin on Tue Apr 01 19:31:33 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
64725-11-7
Created by
admin on Tue Apr 01 19:31:33 GMT 2025 , Edited by admin on Tue Apr 01 19:31:33 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
6QOJ5U08Q0
Created by
admin on Tue Apr 01 19:31:33 GMT 2025 , Edited by admin on Tue Apr 01 19:31:33 GMT 2025
|
PRIMARY | |||
|
123133530
Created by
admin on Tue Apr 01 19:31:33 GMT 2025 , Edited by admin on Tue Apr 01 19:31:33 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD